CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale President and CEO sold 43,851 shares at an average $5.04 ($220,859)
- 4 Planned sale President and CEO sold 16,149 shares at $5.02 ($81,068)
- 4 Planned sale EVP, Global Sales & Marketing sold 14,134 shares at $5.00 ($70,670)
- 4 Planned sale President and CEO sold 15,000 shares at $5.00 ($75,000)
- 4 Planned sale EVP, Global Sales & Marketing sold 34,160 shares at an average $5.02 ($171,616)
- 4 Planned sale President and CEO sold 34,823 shares at an average $5.02 ($174,951)
- 4 Planned sale EVP, Global Sales & Marketing sold 9,973 shares at an average $5.02 ($50,084)
- 4 Planned sale President and CEO sold 10,177 shares at an average $5.02 ($51,110)
- 4 Open-market buy Director bought 80,000 shares at $4.32 ($345,480)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 5 of 9 · 163 filings